| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.08B | -3.8% |
| Cost of Revenue | $403.6M | +4.0% |
| Gross Profit | $676.8M | -7.9% |
| R&D Expense | $37.3M | -52.7% |
| SG&A Expense | $332.0M | -9.1% |
| Operating Income | $242.1M | +45.1% |
| Pre-tax Income | $136.3M | +208.4% |
| Income Tax | $40.9M | +219.9% |
| Net Income | $95.4M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $225.5M | -15.7% |
| Accounts Receivable | $145.6M | -24.6% |
| Inventory | $178.6M | +4.1% |
| Current Assets | $631.4M | -17.0% |
| Total Assets | $1.09B | -15.1% |
| Current Liabilities | $261.5M | -30.1% |
| Long-term Debt | $1.40B | -11.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $191.7M | +437.0% |
| Capital Expenditures | $9.3M | -41.1% |
| Investing Cash Flow | -$9.3M | +41.1% |
| Financing Cash Flow | -$226.7M | -208.9% |
| Free Cash Flow | $182.4M | +816.6% |
| +21.8% |
| EPS (Basic) | $1.64 | +20.6% |
| EPS (Diluted) | $1.62 | +20.9% |
| Stockholders' Equity |
| -$650.6M |
| +11.9% |